The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia.
Chang Y, Keramatnia F, Ghate PS, Nishiguchi G, Gao Q, Iacobucci I, Yang L, Chepyala D, Mishra A, High AA, Goto H, Akahane K, Peng J, Yang JJ, Fischer M, Rankovic Z, Mullighan CG.
Chang Y, et al. Among authors: mishra a.
Blood. 2023 Aug 17;142(7):629-642. doi: 10.1182/blood.2022017813.
Blood. 2023.
PMID: 37172201
Free PMC article.